These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2122514)

  • 21. Alterations in the fibrinolytic system components during acute myocardial infarction.
    Ioannidou-Papayannaki E; Lefkos N; Boudonas G; Efthimiadis A; Psirropoulos D; Vogas V; Papadopoulos I; Klonizakis I
    Acta Cardiol; 2000 Aug; 55(4):247-53. PubMed ID: 11041123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Streptokinase and rt-PA activate platelets by a different way: implications on the rethrombosis rate after their administration in myocardial infarction.
    Parise P; Hauert J; Iorio A; Callegari P; Agnelli G
    J Lab Clin Med; 1995 Feb; 125(2):212-21. PubMed ID: 7531212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The absence of a procoagulant effect after TNK-t-PA: a comparison with streptokinase and rt-PA].
    De Marco E; Andreotti F; van de Greef W; Quaranta G; Biasucci LM; Kol A; Maseri A; Rebuzzi AG
    Cardiologia; 1998 Nov; 43(11):1209-13. PubMed ID: 9922587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery.
    Paganelli F; Alessi MC; Morange P; Maixent JM; Lévy S; Vague IJ
    Thromb Haemost; 1999 Jul; 82(1):104-8. PubMed ID: 10456462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serial changes in coagulant activities after thrombolytic therapy for acute myocardial infarction.
    Goto S; Kawai Y; Abe S; Takahashi E; Handa S; Ogawa S; Watanabe K; Hori S; Ikeda Y
    Angiology; 1994 Apr; 45(4):273-81. PubMed ID: 8161005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rate of fibrinogen breakdown related to coronary patency and bleeding complications in patients with thrombolysis in acute myocardial infarction--results from the PRIMI trial.
    Ostermann H; Schmitz-Huebner U; Windeler J; Bär F; Meyer J; van de Loo J
    Eur Heart J; 1992 Sep; 13(9):1225-32. PubMed ID: 1396833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between admission mean platelet volume and coronary patency after thrombolytic therapy for acute myocardial infarction.
    Yaşar AS; Bilen E; Yüksel IO; Arslantaş U; Karakaş F; Kirbaş O; Bilge M
    Turk Kardiyol Dern Ars; 2010 Mar; 38(2):85-9. PubMed ID: 20473008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increase in thrombin generation after coronary thrombolysis with rt-PA or streptokinase with simultaneous heparin versus heparin alone.
    Réganon E; Ferrando F; Vila V; Villa P; Martínez-Sales V; Fayos L; Ruano M; Aznar J
    Haemostasis; 1998; 28(2):99-105. PubMed ID: 10087435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective inhibition of factor Xa during thrombolytic therapy markedly improves coronary artery patency in a canine model of coronary thrombosis.
    Nicolini FA; Lee P; Malycky JL; Lefkovits J; Kottke-Marchant K; Plow EF; Topol EJ
    Blood Coagul Fibrinolysis; 1996 Jan; 7(1):39-48. PubMed ID: 8845461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrinogen proteolysis and coagulation system activation during thrombolytic therapy.
    Owen J; Grossman B; Sobel J; Kudryk B
    Adv Exp Med Biol; 1990; 281():401-8. PubMed ID: 2129378
    [No Abstract]   [Full Text] [Related]  

  • 31. Rebound increase of plasminogen activator inhibitor type I after cessation of thrombolytic treatment for acute myocardial infarction is independent of type of plasminogen activator used.
    Genser N; Lechleitner P; Maier J; Dienstl F; Artner-Dworzak E; Puschendorf B; Mair J
    Clin Chem; 1998 Feb; 44(2):209-14. PubMed ID: 9474013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of thrombolytic therapies with mutant tPA (lanoteplase/SUN9216) and recombinant tPA (alteplase) for acute myocardial infarction.
    Ogata N; Ogawa H; Ogata Y; Numata Y; Morigami Y; Suefuji H; Soejima H; Sakamoto T; Yasue H
    Jpn Circ J; 1998 Nov; 62(11):801-6. PubMed ID: 9856594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison between intravenous streptokinase and tissue plasminogen activator with early intravenous heparin in acute myocardial infarction.
    Cherng WJ; Chiang CW; Kuo CT; Lee CP; Lee YS
    Am Heart J; 1992 Apr; 123(4 Pt 1):841-6. PubMed ID: 1549990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accelerated ST-segment reduction after thrombolytic therapy with recombinant tissue plasminogen activator (rtPA) compared to urokinase.
    Derad I; Stierle U; Giannitsis E; Potratz J; Born J; Djonlagic H; Fehm HL
    Jpn Heart J; 1996 Jan; 37(1):33-41. PubMed ID: 8632624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of time to treatment on early infarct-related artery patency after different thrombolytic regimens. ALKK-Study Group.
    Zeymer U; Tebbe U; Essen Rv; Haarmann W; Neuhaus KL
    Am Heart J; 1999 Jan; 137(1):34-8. PubMed ID: 9878934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrinogenolysis and thrombin generation after reduced dose bolus or conventional rt-PA for pulmonary embolism. The Coagulation Project Investigators of the Bolus Alteplase Pulmonary Embolism Group.
    Agnelli G; Iorio A; Parise P; Goldhaber SZ; Levine MN
    Blood Coagul Fibrinolysis; 1997 Jun; 8(4):216-22. PubMed ID: 9199818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New thrombolytic agents in myocardial infarction].
    Charbonnier B; Lang M; Brochier M
    Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombin generation and activity during thrombolysis and concomitant heparin therapy in patients with acute myocardial infarction.
    Merlini PA; Bauer KA; Oltrona L; Ardissino D; Spinola A; Cattaneo M; Broccolino M; Mannucci PM; Rosenberg RD
    J Am Coll Cardiol; 1995 Jan; 25(1):203-9. PubMed ID: 7798503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Thrombolysis in acute myocardial infarction. Streptokinase or r-TPA?].
    Silva LA; Ribeiro E; Carneiro RC; Kaissar S; Reis Filho A; Torossian SP; Tavares JR; Buffolo E; Amino JG; Duprat Filho R
    Arq Bras Cardiol; 1990 Jul; 55(1):13-7. PubMed ID: 2127353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The incidence and mechanism of hypotension following thrombolytic therapy for acute myocardial infarction with streptokinase-containing agents--lack of relationship to pretreatment streptokinase resistance.
    Gemmill JD; Hogg KJ; Douglas JT; Dunn FG; Lowe GD; Rae AP; Hillis WS
    Eur Heart J; 1993 Jun; 14(6):819-25. PubMed ID: 8325311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.